Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Res Notes ; 9: 229, 2016 Apr 22.
Article in English | MEDLINE | ID: mdl-27103162

ABSTRACT

BACKGROUND: Persons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse. METHODS: We performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved. RESULTS: Participants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care. CONCLUSIONS: PLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , Patient Acceptance of Health Care/statistics & numerical data , Qualitative Research , Substance-Related Disorders/complications , Continuity of Patient Care/statistics & numerical data , Female , HIV Infections/complications , HIV Infections/psychology , Health Services Accessibility/statistics & numerical data , Humans , Interviews as Topic , Male , Medication Adherence/statistics & numerical data , Middle Aged , Social Support , Substance-Related Disorders/psychology
SELECTION OF CITATIONS
SEARCH DETAIL
...